aluates Reports

$ 0.0

Automative

Global Neuroprotection Market Research Report 2025

Published Date: August 2025

Report Code: QYRE-Auto-1A4377

Global Neuroprotection Market Insights and Forecast to 2028

BUY CHAPTERS

Global Neuroprotection Market Research Report 2025

Code: QYRE-Auto-1A4377

Report

August 2025

Pages:72

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

F.Hoffmann-La Roche

Eli Lilly and Company

Daiichi Sankyo Company

Allergan plc

Novartis

Astrazeneca plc

Dr. Reddy’s Laboratories

Astrocyte Pharmaceuticals

Teva Pharmaceutical Industries

Biogen

Neuroprotection Market Size

The global market for Neuroprotection was valued at US$ 26190 million in the year 2024 and is projected to reach a revised size of US$ 35490 million by 2031, growing at a CAGR of 4.5% during the forecast period.

Neuroprotection Market

Neuroprotection refers to strategies and treatments aimed at preserving the structure and function of neurons in the nervous system. It is critical for conditions like stroke and neurodegenerative diseases.

As the aging population grows, neuroprotection research and therapies are on the rise. Potential treatments for diseases like Alzheimer"s are a significant focus.

This report aims to provide a comprehensive presentation of the global market for Neuroprotection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuroprotection.

The Neuroprotection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neuroprotection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Neuroprotection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Neuroprotection Market Report

Report Metric	Details
Report Name	Neuroprotection Market
Accounted market size in year	US$ 26190 million
Forecasted market size in 2031	US$ 35490 million
CAGR	4.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Free Anti-Inflammatory Agents Radical Trapping Agents (Antioxidants) Apoptosis Inhibitors Glutamate Antagonists (Anti-Excitotoxic Agents) Neurotrophic Factors (NTFs) Stimulants Metal Ion Chelators Others
Segment by Application	Prevention Treatment
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	F. Hoffmann-La Roche, Eli Lilly and Company, Daiichi Sankyo Company, Allergan, Novartis, AstraZeneca, Dr. Reddy's Laboratories, Astrocyte Pharmaceuticals, Teva Pharmaceutical Industries, Biogen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neuroprotection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Neuroprotection Market growing?

Ans: The Neuroprotection Market witnessing a CAGR of 4.5% during the forecast period 2025-2031.

What is the Neuroprotection Market size in 2031?

Ans: The Neuroprotection Market size in 2031 will be US$ 35490 million.

Who are the main players in the Neuroprotection Market report?

Ans: The main players in the Neuroprotection Market are F. Hoffmann-La Roche, Eli Lilly and Company, Daiichi Sankyo Company, Allergan, Novartis, AstraZeneca, Dr. Reddy's Laboratories, Astrocyte Pharmaceuticals, Teva Pharmaceutical Industries, Biogen

What are the Application segmentation covered in the Neuroprotection Market report?

Ans: The Applications covered in the Neuroprotection Market report are Prevention, Treatment

What are the Type segmentation covered in the Neuroprotection Market report?

Ans: The Types covered in the Neuroprotection Market report are Free Anti-Inflammatory Agents, Radical Trapping Agents (Antioxidants), Apoptosis Inhibitors, Glutamate Antagonists (Anti-Excitotoxic Agents), Neurotrophic Factors (NTFs), Stimulants, Metal Ion Chelators, Others

Recommended Reports

Neurodegenerative Treatment

Neuroprotective Devices

Neurorehabilitation Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Neuroprotection Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Free Anti-Inflammatory Agents

1.2.3 Radical Trapping Agents (Antioxidants)

1.2.4 Apoptosis Inhibitors

1.2.5 Glutamate Antagonists (Anti-Excitotoxic Agents)

1.2.6 Neurotrophic Factors (NTFs)

1.2.7 Stimulants

1.2.8 Metal Ion Chelators

1.2.9 Others

1.3 Market by Application

1.3.1 Global Neuroprotection Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Prevention

1.3.3 Treatment

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Neuroprotection Market Perspective (2020-2031)

2.2 Global Neuroprotection Growth Trends by Region

2.2.1 Global Neuroprotection Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Neuroprotection Historic Market Size by Region (2020-2025)

2.2.3 Neuroprotection Forecasted Market Size by Region (2026-2031)

2.3 Neuroprotection Market Dynamics

2.3.1 Neuroprotection Industry Trends

2.3.2 Neuroprotection Market Drivers

2.3.3 Neuroprotection Market Challenges

2.3.4 Neuroprotection Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Neuroprotection Players by Revenue

3.1.1 Global Top Neuroprotection Players by Revenue (2020-2025)

3.1.2 Global Neuroprotection Revenue Market Share by Players (2020-2025)

3.2 Global Neuroprotection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Neuroprotection Revenue

3.4 Global Neuroprotection Market Concentration Ratio

3.4.1 Global Neuroprotection Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Neuroprotection Revenue in 2024

3.5 Global Key Players of Neuroprotection Head office and Area Served

3.6 Global Key Players of Neuroprotection, Product and Application

3.7 Global Key Players of Neuroprotection, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Neuroprotection Breakdown Data by Type

4.1 Global Neuroprotection Historic Market Size by Type (2020-2025)

4.2 Global Neuroprotection Forecasted Market Size by Type (2026-2031)

5 Neuroprotection Breakdown Data by Application

5.1 Global Neuroprotection Historic Market Size by Application (2020-2025)

5.2 Global Neuroprotection Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Neuroprotection Market Size (2020-2031)

6.2 North America Neuroprotection Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Neuroprotection Market Size by Country (2020-2025)

6.4 North America Neuroprotection Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Neuroprotection Market Size (2020-2031)

7.2 Europe Neuroprotection Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Neuroprotection Market Size by Country (2020-2025)

7.4 Europe Neuroprotection Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Neuroprotection Market Size (2020-2031)

8.2 Asia-Pacific Neuroprotection Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Neuroprotection Market Size by Region (2020-2025)

8.4 Asia-Pacific Neuroprotection Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Neuroprotection Market Size (2020-2031)

9.2 Latin America Neuroprotection Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Neuroprotection Market Size by Country (2020-2025)

9.4 Latin America Neuroprotection Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Neuroprotection Market Size (2020-2031)

10.2 Middle East & Africa Neuroprotection Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Neuroprotection Market Size by Country (2020-2025)

10.4 Middle East & Africa Neuroprotection Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 F. Hoffmann-La Roche

11.1.1 F. Hoffmann-La Roche Company Details

11.1.2 F. Hoffmann-La Roche Business Overview

11.1.3 F. Hoffmann-La Roche Neuroprotection Introduction

11.1.4 F. Hoffmann-La Roche Revenue in Neuroprotection Business (2020-2025)

11.1.5 F. Hoffmann-La Roche Recent Development

11.2 Eli Lilly and Company

11.2.1 Eli Lilly and Company Company Details

11.2.2 Eli Lilly and Company Business Overview

11.2.3 Eli Lilly and Company Neuroprotection Introduction

11.2.4 Eli Lilly and Company Revenue in Neuroprotection Business (2020-2025)

11.2.5 Eli Lilly and Company Recent Development

11.3 Daiichi Sankyo Company

11.3.1 Daiichi Sankyo Company Company Details

11.3.2 Daiichi Sankyo Company Business Overview

11.3.3 Daiichi Sankyo Company Neuroprotection Introduction

11.3.4 Daiichi Sankyo Company Revenue in Neuroprotection Business (2020-2025)

11.3.5 Daiichi Sankyo Company Recent Development

11.4 Allergan

11.4.1 Allergan Company Details

11.4.2 Allergan Business Overview

11.4.3 Allergan Neuroprotection Introduction

11.4.4 Allergan Revenue in Neuroprotection Business (2020-2025)

11.4.5 Allergan Recent Development

11.5 Novartis

11.5.1 Novartis Company Details

11.5.2 Novartis Business Overview

11.5.3 Novartis Neuroprotection Introduction

11.5.4 Novartis Revenue in Neuroprotection Business (2020-2025)

11.5.5 Novartis Recent Development

11.6 AstraZeneca

11.6.1 AstraZeneca Company Details

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Neuroprotection Introduction

11.6.4 AstraZeneca Revenue in Neuroprotection Business (2020-2025)

11.6.5 AstraZeneca Recent Development

11.7 Dr. Reddy's Laboratories

11.7.1 Dr. Reddy's Laboratories Company Details

11.7.2 Dr. Reddy's Laboratories Business Overview

11.7.3 Dr. Reddy's Laboratories Neuroprotection Introduction

11.7.4 Dr. Reddy's Laboratories Revenue in Neuroprotection Business (2020-2025)

11.7.5 Dr. Reddy's Laboratories Recent Development

11.8 Astrocyte Pharmaceuticals

11.8.1 Astrocyte Pharmaceuticals Company Details

11.8.2 Astrocyte Pharmaceuticals Business Overview

11.8.3 Astrocyte Pharmaceuticals Neuroprotection Introduction

11.8.4 Astrocyte Pharmaceuticals Revenue in Neuroprotection Business (2020-2025)

11.8.5 Astrocyte Pharmaceuticals Recent Development

11.9 Teva Pharmaceutical Industries

11.9.1 Teva Pharmaceutical Industries Company Details

11.9.2 Teva Pharmaceutical Industries Business Overview

11.9.3 Teva Pharmaceutical Industries Neuroprotection Introduction

11.9.4 Teva Pharmaceutical Industries Revenue in Neuroprotection Business (2020-2025)

11.9.5 Teva Pharmaceutical Industries Recent Development

11.10 Biogen

11.10.1 Biogen Company Details

11.10.2 Biogen Business Overview

11.10.3 Biogen Neuroprotection Introduction

11.10.4 Biogen Revenue in Neuroprotection Business (2020-2025)

11.10.5 Biogen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

F.Hoffmann-La Roche

Eli Lilly and Company

Daiichi Sankyo Company

Allergan plc

Novartis

Astrazeneca plc

Dr. Reddy’s Laboratories

Astrocyte Pharmaceuticals

Teva Pharmaceutical Industries

Biogen

List of Tables

Table 1. Global Neuroprotection Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Free Anti-Inflammatory Agents

Table 3. Key Players of Radical Trapping Agents (Antioxidants)

Table 4. Key Players of Apoptosis Inhibitors

Table 5. Key Players of Glutamate Antagonists (Anti-Excitotoxic Agents)

Table 6. Key Players of Neurotrophic Factors (NTFs)

Table 7. Key Players of Stimulants

Table 8. Key Players of Metal Ion Chelators

Table 9. Global Neuroprotection Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Neuroprotection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Neuroprotection Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Neuroprotection Market Share by Region (2020-2025)

Table 13. Global Neuroprotection Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Neuroprotection Market Share by Region (2026-2031)

Table 15. Neuroprotection Market Trends

Table 16. Neuroprotection Market Drivers

Table 17. Neuroprotection Market Challenges

Table 18. Neuroprotection Market Restraints

Table 19. Global Neuroprotection Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Neuroprotection Market Share by Players (2020-2025)

Table 21. Global Top Neuroprotection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroprotection as of 2024)

Table 22. Ranking of Global Top Neuroprotection Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Neuroprotection Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Neuroprotection, Headquarters and Area Served

Table 25. Global Key Players of Neuroprotection, Product and Application

Table 26. Global Key Players of Neuroprotection, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Neuroprotection Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Neuroprotection Revenue Market Share by Type (2020-2025)

Table 30. Global Neuroprotection Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Neuroprotection Revenue Market Share by Type (2026-2031)

Table 32. Global Neuroprotection Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Neuroprotection Revenue Market Share by Application (2020-2025)

Table 34. Global Neuroprotection Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Neuroprotection Revenue Market Share by Application (2026-2031)

Table 36. North America Neuroprotection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Neuroprotection Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Neuroprotection Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Neuroprotection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Neuroprotection Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Neuroprotection Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Neuroprotection Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Neuroprotection Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Neuroprotection Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Neuroprotection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Neuroprotection Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Neuroprotection Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Neuroprotection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Neuroprotection Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Neuroprotection Market Size by Country (2026-2031) & (US$ Million)

Table 51. F. Hoffmann-La Roche Company Details

Table 52. F. Hoffmann-La Roche Business Overview

Table 53. F. Hoffmann-La Roche Neuroprotection Product

Table 54. F. Hoffmann-La Roche Revenue in Neuroprotection Business (2020-2025) & (US$ Million)

Table 55. F. Hoffmann-La Roche Recent Development

Table 56. Eli Lilly and Company Company Details

Table 57. Eli Lilly and Company Business Overview

Table 58. Eli Lilly and Company Neuroprotection Product

Table 59. Eli Lilly and Company Revenue in Neuroprotection Business (2020-2025) & (US$ Million)

Table 60. Eli Lilly and Company Recent Development

Table 61. Daiichi Sankyo Company Company Details

Table 62. Daiichi Sankyo Company Business Overview

Table 63. Daiichi Sankyo Company Neuroprotection Product

Table 64. Daiichi Sankyo Company Revenue in Neuroprotection Business (2020-2025) & (US$ Million)

Table 65. Daiichi Sankyo Company Recent Development

Table 66. Allergan Company Details

Table 67. Allergan Business Overview

Table 68. Allergan Neuroprotection Product

Table 69. Allergan Revenue in Neuroprotection Business (2020-2025) & (US$ Million)

Table 70. Allergan Recent Development

Table 71. Novartis Company Details

Table 72. Novartis Business Overview

Table 73. Novartis Neuroprotection Product

Table 74. Novartis Revenue in Neuroprotection Business (2020-2025) & (US$ Million)

Table 75. Novartis Recent Development

Table 76. AstraZeneca Company Details

Table 77. AstraZeneca Business Overview

Table 78. AstraZeneca Neuroprotection Product

Table 79. AstraZeneca Revenue in Neuroprotection Business (2020-2025) & (US$ Million)

Table 80. AstraZeneca Recent Development

Table 81. Dr. Reddy's Laboratories Company Details

Table 82. Dr. Reddy's Laboratories Business Overview

Table 83. Dr. Reddy's Laboratories Neuroprotection Product

Table 84. Dr. Reddy's Laboratories Revenue in Neuroprotection Business (2020-2025) & (US$ Million)

Table 85. Dr. Reddy's Laboratories Recent Development

Table 86. Astrocyte Pharmaceuticals Company Details

Table 87. Astrocyte Pharmaceuticals Business Overview

Table 88. Astrocyte Pharmaceuticals Neuroprotection Product

Table 89. Astrocyte Pharmaceuticals Revenue in Neuroprotection Business (2020-2025) & (US$ Million)

Table 90. Astrocyte Pharmaceuticals Recent Development

Table 91. Teva Pharmaceutical Industries Company Details

Table 92. Teva Pharmaceutical Industries Business Overview

Table 93. Teva Pharmaceutical Industries Neuroprotection Product

Table 94. Teva Pharmaceutical Industries Revenue in Neuroprotection Business (2020-2025) & (US$ Million)

Table 95. Teva Pharmaceutical Industries Recent Development

Table 96. Biogen Company Details

Table 97. Biogen Business Overview

Table 98. Biogen Neuroprotection Product

Table 99. Biogen Revenue in Neuroprotection Business (2020-2025) & (US$ Million)

Table 100. Biogen Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

Table 104. Authors List of This Report

List of Figures

Figure 1. Neuroprotection Picture

Figure 2. Global Neuroprotection Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Neuroprotection Market Share by Type: 2024 VS 2031

Figure 4. Free Anti-Inflammatory Agents Features

Figure 5. Radical Trapping Agents (Antioxidants) Features

Figure 6. Apoptosis Inhibitors Features

Figure 7. Glutamate Antagonists (Anti-Excitotoxic Agents) Features

Figure 8. Neurotrophic Factors (NTFs) Features

Figure 9. Stimulants Features

Figure 10. Metal Ion Chelators Features

Figure 11. Others Features

Figure 12. Global Neuroprotection Market Size by Application (2020-2031) & (US$ Million)

Figure 13. Global Neuroprotection Market Share by Application: 2024 VS 2031

Figure 14. Prevention Case Studies

Figure 15. Treatment Case Studies

Figure 16. Neuroprotection Report Years Considered

Figure 17. Global Neuroprotection Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Neuroprotection Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Neuroprotection Market Share by Region: 2024 VS 2031

Figure 20. Global Neuroprotection Market Share by Players in 2024

Figure 21. Global Top Neuroprotection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroprotection as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Neuroprotection Revenue in 2024

Figure 23. North America Neuroprotection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Neuroprotection Market Share by Country (2020-2031)

Figure 25. United States Neuroprotection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Neuroprotection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Neuroprotection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Neuroprotection Market Share by Country (2020-2031)

Figure 29. Germany Neuroprotection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Neuroprotection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Neuroprotection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Neuroprotection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Neuroprotection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Neuroprotection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Neuroprotection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Neuroprotection Market Share by Region (2020-2031)

Figure 37. China Neuroprotection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Neuroprotection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Neuroprotection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Neuroprotection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Neuroprotection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia Neuroprotection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Neuroprotection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Neuroprotection Market Share by Country (2020-2031)

Figure 45. Mexico Neuroprotection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Neuroprotection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Neuroprotection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Neuroprotection Market Share by Country (2020-2031)

Figure 49. Turkey Neuroprotection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Neuroprotection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Neuroprotection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. F. Hoffmann-La Roche Revenue Growth Rate in Neuroprotection Business (2020-2025)

Figure 53. Eli Lilly and Company Revenue Growth Rate in Neuroprotection Business (2020-2025)

Figure 54. Daiichi Sankyo Company Revenue Growth Rate in Neuroprotection Business (2020-2025)

Figure 55. Allergan Revenue Growth Rate in Neuroprotection Business (2020-2025)

Figure 56. Novartis Revenue Growth Rate in Neuroprotection Business (2020-2025)

Figure 57. AstraZeneca Revenue Growth Rate in Neuroprotection Business (2020-2025)

Figure 58. Dr. Reddy's Laboratories Revenue Growth Rate in Neuroprotection Business (2020-2025)

Figure 59. Astrocyte Pharmaceuticals Revenue Growth Rate in Neuroprotection Business (2020-2025)

Figure 60. Teva Pharmaceutical Industries Revenue Growth Rate in Neuroprotection Business (2020-2025)

Figure 61. Biogen Revenue Growth Rate in Neuroprotection Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Neuroprotective Drugs Market Research Report 2024

Global Neuroprotective Agents Market Insights Forecast to 2030

Global Neurorehabilitation Therapy Market Insights Forecast to 2030

Global Neurodegenerative Disease Treatment Market Research Report 2024

Global Neurodegenerative Disorder Therapeutics Market Research Report 2024

Dementia and Alzheimer s Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Neuroscience Medical Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rare Neurodegenerative Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Neurodegenerative Disease Market Insights Forecast to 2030

Global Digital Therapeutics for Nervous System Diseases Market Research Report 2024

Global Neurorehabilitation System Market Research Report 2024

Global Assisted Living Facility And Neurorehabilitation Market Research Report 2024

Central Nervous System Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drugs for Central Nervous System Diseases Market Insights Forecast to 2030

Global Nerve Repair and Regeneration Devices Market Research Report 2024

Gene Therapy in CNS Disorder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Central Nervous System Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Neurorehabilitation Gaming Systems Market Research Report 2024

Neurotechnology Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions